ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Virginia » Ophthalmology

Top Ophthalmology Prescribers in Virginia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
FRANK COTTER M.D.

Ophthalmology

9,230

$588K

1161
1063 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

50%
prescriptions for brand name drugs

Avg: 56%

$64
Average prescription price

Avg: $73

FRANCIS LAROSA M.D.

Ophthalmology

6,298

$323K

832
766 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

46%
prescriptions for brand name drugs

Avg: 56%

$51
Average prescription price

Avg: $73

ELIZENDA CEBALLOS M.D.

Ophthalmology

6,101

$499K

774
690 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

64%
prescriptions for brand name drugs

Avg: 56%

$82
Average prescription price

Avg: $73

KAREN FITZGERALD-SHELTON MD

Ophthalmology

5,296

$436K

734
625 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

65%
prescriptions for brand name drugs

Avg: 56%

$82
Average prescription price

Avg: $73

JAMES PARK M.D., PH.D.

Ophthalmology

5,136

$608K

863
833 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

62%
prescriptions for brand name drugs

Avg: 56%

$118
Average prescription price

Avg: $73

JOHN SHEPPARD M.D.

Ophthalmology

4,988

$677K

830
668 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

74%
prescriptions for brand name drugs

Avg: 56%

$136
Average prescription price

Avg: $73

ANDREW MICHAEL MD

Ophthalmology

4,617

$286K

1133
1040 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

65%
prescriptions for brand name drugs

Avg: 56%

$62
Average prescription price

Avg: $73

WALTER BUNDY M.D.

Ophthalmology

4,067

$266K

515
488 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

53%
prescriptions for brand name drugs

Avg: 56%

$65
Average prescription price

Avg: $73

DAVID HARMAN MD

Ophthalmology

4,035

$186K

882
828 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

50%
prescriptions for brand name drugs

Avg: 56%

$46
Average prescription price

Avg: $73

LEONARD RAPPAPORT MD

Ophthalmology

4,006

$390K

611
539 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

69%
prescriptions for brand name drugs

Avg: 56%

$97
Average prescription price

Avg: $73

GENE MOSS MD

Ophthalmology

3,881

$372K

702
635 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

70%
prescriptions for brand name drugs

Avg: 56%

$96
Average prescription price

Avg: $73

SCOTT STRELOW M.D.

Ophthalmology

3,747

$149K

698
614 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

54%
prescriptions for brand name drugs

Avg: 56%

$40
Average prescription price

Avg: $73

PAUL GRIFFEY M.D.

Ophthalmology

3,637

$270K

682
613 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

61%
prescriptions for brand name drugs

Avg: 56%

$74
Average prescription price

Avg: $73

HAROLD BERNSTEIN M.D.

Ophthalmology

3,603

$292K

516
472 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

62%
prescriptions for brand name drugs

Avg: 56%

$81
Average prescription price

Avg: $73

BRUCE PRUM

Ophthalmology

3,502

$284K

449
416 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

59%
prescriptions for brand name drugs

Avg: 56%

$81
Average prescription price

Avg: $73

TEDD PUCKETT MD

Ophthalmology

3,303

$195K

709
652 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

43%
prescriptions for brand name drugs

Avg: 56%

$59
Average prescription price

Avg: $73

ETHNIE JONES M.D.

Ophthalmology

3,226

$193K

506
426 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

53%
prescriptions for brand name drugs

Avg: 56%

$60
Average prescription price

Avg: $73

MARK MORRIS MD

Ophthalmology

3,192

$223K

746
668 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

47%
prescriptions for brand name drugs

Avg: 56%

$70
Average prescription price

Avg: $73

RIPON LA ROCHE MD

Ophthalmology

3,076

$137K

537
505 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

41%
prescriptions for brand name drugs

Avg: 56%

$45
Average prescription price

Avg: $73

DONALD GRAYSON MD

Ophthalmology

2,957

$231K

628
571 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

60%
prescriptions for brand name drugs

Avg: 56%

$78
Average prescription price

Avg: $73

FREDRIC GROSS M.D.

Ophthalmology

2,886

$194K

618
527 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

60%
prescriptions for brand name drugs

Avg: 56%

$67
Average prescription price

Avg: $73

WILLIAM ROSENBERGER M.D.

Ophthalmology

2,770

$158K

547
497 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

46%
prescriptions for brand name drugs

Avg: 56%

$57
Average prescription price

Avg: $73

WILLIAM WASCHLER M.D.

Ophthalmology

2,710

$184K

582
514 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

54%
prescriptions for brand name drugs

Avg: 56%

$68
Average prescription price

Avg: $73

TERRY ODOM MD

Ophthalmology

2,635

$157K

583
535 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

56%
prescriptions for brand name drugs

Avg: 56%

$60
Average prescription price

Avg: $73

ARASH MANSOURI MD

Ophthalmology

2,578

$108K

631
567 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

37%
prescriptions for brand name drugs

Avg: 56%

$42
Average prescription price

Avg: $73

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank